We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Healthcare’s Three Big Forecasts: mHealth, Cloud Healthcare, and Regulator Environments

By LabMedica International staff writers
Posted on 09 Dec 2013
A new market research report, based on a 2013 growth survey, identified major areas of eHealth technology and integration with other businesses. More...


Frost & Sullivan (Mountain View, CA, USA), an international growth consultancy company, reported in December 2013 its three big predictions for the global healthcare market. Based on a “2013 Search for Growth” survey, which involved 1,835 executives in more than 40 countries worldwide, Frost & Sullivan’s insight highlighted new fields of growth and stated that mHealth (mobile health), the cloud in healthcare, and regulatory environments will be the major themes in 2014 and beyond.

“Frost & Sullivan’s research team has used the findings to select and prioritize the subjects that are deemed to be poised for the greatest growth,” explained Frost & Sullivan partner Dorman Followwill. “The insight has also been essential in unveiling the business outlook for pharmaceuticals, biotechnology, clinical diagnostics, and medical devices, as well as to provide a global perspective on the industry’s geographic hot spots.

mHealth expansion has been fuelled by the unprecedented spread of mobile technologies, as well as further developments in their novel application to address health priorities. It is mostly supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs) and other wireless devices. The penetration outlook of mHealth technologies is significant in the following areas: wireless vital signs monitoring, location-aware telemonitoring systems, and Bluetooth wireless technology-enabled health trackers. It is a promising area of opportunity for healthcare growth and it will provide novel systems for participants and for both providers and patients across the spectrum.

Furthermore, as more healthcare information technology (IT) and patient monitoring tools are incorporated, every hospital facility will ultimately have to acquire a fully-enterprise wireless solution. The most innovative mobile healthcare solutions that best meet pressing healthcare needs will be adopted as the gold standard.

Enterprise-wide healthcare informatics will also improve the quality of medical services and efficiency of operations while slashing costs. Cloud computing is considered to be an essential enabler for enterprise-wide systems. Implementing cloud computing technologies correctly will help healthcare providers improve the quality of medical services and the effectiveness of operations, share data across geographic locations, and manage costs. The model can be applied in a range of ways, including data storage and data loss prevention, maintaining patient information records and authorized sharing of information.

The benefits that cloud computing provide can change the dynamics of the healthcare informatics industry over time. The need for efficient sharing of information across locations in a synchronized way will be a key driver for cloud computing in healthcare.

As for regulatory environment, recent healthcare reforms and policy initiatives across many countries have stressed the importance of quality of care more than quantity. In the absence of a sufficient proof of clinical benefit, reimbursements may become a major obstacle.

Overall, three big predictions may be expressed based on the survey’s findings: (1) as healthcare moves towards a customized medicine model, companion diagnostics will change drug development and the marketing process of drug candidates. Combining biomarkers and drugs will result in enhanced therapeutic efficacy and safety. (2) The healthcare and life sciences industry will additionally consolidate in this decade, with many big pharma companies looking for alternatives to the blockbuster model. (3) Lastly, the increase of new technologies capable of integrating medical devices into a connected platform will enhance the functionality of devices, decrease labor burden, and curtail errors.

Other significant areas that have emerged from the same survey include cancer market outlook, remote monitoring, drug delivery market, patient and consumer engagement, eHealth medical records, dashboards, medical devices growth drivers, drug discovery research outsourcing market, homecare market trends, video telemedicine, and cardiovascular therapeutics.

Frost & Sullivan collaborates with clients to utilize recent developments that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Related Links:

Frost & Sullivan



New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Colorectal cancer under the microscope (Photo courtesy of Adobe Stock)

Unique Microbial Fingerprint to Improve Diagnosis of Colorectal Cancer

Colorectal cancer is the fourth most common cancer in the UK and the second deadliest. New research has revealed that it carries a unique microbial fingerprint, which could help doctors better understand... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.